AI assistant
Sending…
Imunon, Inc. — Director's Dealing 2025
Feb 18, 2025
35124_dirs_2025-02-18_2b5fa660-7357-40e3-b5b5-0ddaa881e0ea.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Imunon, Inc. (IMNN)
CIK: 0000749647
Period of Report: 2025-02-18
Reporting Person: Faller Douglas Vincent (Chief Medical Officer)
More from Imunon, Inc.
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12
Annual Report
2026
May 4
Regulatory Filings
2026
May 4
Proxy Solicitation & Information Statement
2026
May 4
Annual Report
2026
Mar 31
Regulatory Filings
2026
Mar 31
Capital/Financing Update
2026
Mar 23
Regulatory Filings
2026
Mar 23
Major Shareholding Notification
2026
Feb 18